KalVista Pharmaceuticals, Inc. (KALV)
16.23
+0.02
(+0.12%)
USD |
NASDAQ |
Mar 06, 16:00
16.31
+0.08
(+0.49%)
After-Hours: 20:00
KalVista Pharmaceuticals SG&A Expense (TTM) : 160.68M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 119.80M |
| Recursion Pharmaceuticals, Inc. | 176.59M |
| Tango Therapeutics, Inc. | 31.74M |
| Modular Medical, Inc. | 6.786M |
| Iovance Biotherapeutics, Inc. | 152.58M |